Of note, the detected lowering in Bcl2 immunostaining area % could be due to neuronal loss; shrinkage of the neuronal soma, which has been reported as a common pathological outcome in Alzheimer’s disease; or both [30]. This evidence concerns the gene BCL2 and early-onset autosomal dominant Alzheimer disease.